| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.00064 | 1 |